All Episodes

January 4, 2021 14 min
In this podcast, Contributing Editor Dr. Irene Ghobrial has a conversation with Dr. Shaji Kumar. They discuss Dr. Ghobrial’s Year’s Best article from the January/February 2021 issue of The Hematologist, titled, "The BELLINI Study and the Dawn of Precision Medicine in Multiple Myeloma." They discuss a randomized, double-blinded, phase III trial testing the combination of venetoclax or placebo with bortezomib and dexamethasone in relapsed or refractory multiple myeloma. You can access her Year’s Best article online at Conflicts of Interest: Dr. Kumar has received research funding for clinical trials to the institution from Abbvie, Amgen, BMS, Carsgen, Janssen, KITE, Merck, Medimmune, Novartis, Roche-Genentech, Takeda, and Tenebio, and has consulted or participated in advisory boards (with no personal payments) for Abbvie, Amgen, BMS, Janssen, Roche-Genentech, Takeda, and (with personal payment) Oncopeptides, Beigene. Dr. Ghobrial has consulted for GSK (and Advisory Board participation), Sanofi, Janssen, Takeda, Karyopharm, AbbVie, GNS (Ad. Board participation), Cellectar, Medscape, Genentech, Adaptive, BMS, Aptitude (Ad. Board participation), and Curio Science. Music: “Jellyfish in Space” Kevin MacLeod ( Licensed under Creative Commons: By Attribution 3.0
Mark as Played

Advertise With Us

Popular Podcasts

Crime Junkie
Dateline NBC

Dateline NBC

Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations.

Stuff You Should Know

Stuff You Should Know

If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks then look no further. Josh and Chuck have you covered.

For You

    Music, radio and podcasts, all free. Listen online or download the iHeart App.


    © 2021 iHeartMedia, Inc.

    • Help
    • Privacy Policy
    • Terms of Use
    • AdChoicesAd Choices